2020
DOI: 10.1007/s00277-020-03918-6
|View full text |Cite
|
Sign up to set email alerts
|

RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
23
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 26 publications
(25 citation statements)
references
References 43 publications
2
23
0
Order By: Relevance
“…To the Editor: Follicular lymphoma (FL) is the most frequent indolent B-cell lymphoma. 1 The introduction of immunotherapy has greatly improved outcomes for FL patients, with a median overall survival (OS) now approaching 20 years. 2,3 However, relapses are continuously seen during follow-up, and responses progressively shorten with each relapse, with a median survival after third-line therapy of 4.8 years.…”
Section: The Interval Between Frontline Treatment and The Second Relapse (Pfs2) Predicts Survival From The Second Relapse In Follicular Lmentioning
confidence: 99%
“…To the Editor: Follicular lymphoma (FL) is the most frequent indolent B-cell lymphoma. 1 The introduction of immunotherapy has greatly improved outcomes for FL patients, with a median overall survival (OS) now approaching 20 years. 2,3 However, relapses are continuously seen during follow-up, and responses progressively shorten with each relapse, with a median survival after third-line therapy of 4.8 years.…”
Section: The Interval Between Frontline Treatment and The Second Relapse (Pfs2) Predicts Survival From The Second Relapse In Follicular Lmentioning
confidence: 99%
“…[ 6 ] Similarly, in Spain, between 2014 and 2018, NHL of B-cell origin and HL represented 80% and 12.4% of all lymphomas, respectively; the overall 2-year survival rate after diagnosis was 92% in HL. [ 7 ] In Canada, a study found that NHL and HL accounted for 90% and 6% of all lymphomas, respectively,[ 8 ] while in the United States, these two subtypes accounted for 90% and 10% of the lymphomas, respectively. [ 4 ]…”
Section: Introductionmentioning
confidence: 99%
“…Aggressive subtypes of B-cell NHL include diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma [1]. DLBCL is the most common subtype of B-cell NHL, accounting for approximately 30% of newly diagnosed cases of NHL, with an estimated incidence of 3.8/100,000 per year in Europe [2,3].…”
Section: Introductionmentioning
confidence: 99%